DK164501C - Fremgangsmaade til fremstilling af nizatidin og mellemprodukt til brug ved fremgangsmaaden - Google Patents

Fremgangsmaade til fremstilling af nizatidin og mellemprodukt til brug ved fremgangsmaaden

Info

Publication number
DK164501C
DK164501C DK051984A DK51984A DK164501C DK 164501 C DK164501 C DK 164501C DK 051984 A DK051984 A DK 051984A DK 51984 A DK51984 A DK 51984A DK 164501 C DK164501 C DK 164501C
Authority
DK
Denmark
Prior art keywords
procedure
nizatidine
manufacturing
intermediate products
methyl
Prior art date
Application number
DK051984A
Other languages
Danish (da)
English (en)
Other versions
DK164501B (da
DK51984A (da
DK51984D0 (da
Inventor
Charles Wilbur Ryan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23843341&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK164501(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK51984D0 publication Critical patent/DK51984D0/da
Publication of DK51984A publication Critical patent/DK51984A/da
Publication of DK164501B publication Critical patent/DK164501B/da
Application granted granted Critical
Publication of DK164501C publication Critical patent/DK164501C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Credit Cards Or The Like (AREA)
DK051984A 1983-02-07 1984-02-06 Fremgangsmaade til fremstilling af nizatidin og mellemprodukt til brug ved fremgangsmaaden DK164501C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46429683A 1983-02-07 1983-02-07
US46429683 1983-02-07

Publications (4)

Publication Number Publication Date
DK51984D0 DK51984D0 (da) 1984-02-06
DK51984A DK51984A (da) 1984-08-08
DK164501B DK164501B (da) 1992-07-06
DK164501C true DK164501C (da) 1992-11-23

Family

ID=23843341

Family Applications (2)

Application Number Title Priority Date Filing Date
DK051984A DK164501C (da) 1983-02-07 1984-02-06 Fremgangsmaade til fremstilling af nizatidin og mellemprodukt til brug ved fremgangsmaaden
DK021292A DK164906C (da) 1983-02-07 1992-02-19 Isothiourinstof-derivat og fremgangsmaade til fremstilling deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK021292A DK164906C (da) 1983-02-07 1992-02-19 Isothiourinstof-derivat og fremgangsmaade til fremstilling deraf

Country Status (27)

Country Link
EP (1) EP0116452B1 (ko)
JP (1) JPS59152378A (ko)
KR (1) KR860000767B1 (ko)
AT (1) ATE84530T1 (ko)
AU (1) AU559639B2 (ko)
BG (1) BG45216A3 (ko)
CA (1) CA1221369A (ko)
CS (1) CS240994B2 (ko)
DD (1) DD216459A5 (ko)
DE (1) DE3486032T2 (ko)
DK (2) DK164501C (ko)
EG (1) EG17702A (ko)
ES (1) ES529492A0 (ko)
FI (1) FI840474A (ko)
GB (1) GB2134521B (ko)
GR (1) GR81755B (ko)
HU (2) HU190527B (ko)
IE (1) IE56763B1 (ko)
IL (1) IL70880A (ko)
NZ (1) NZ207046A (ko)
PH (1) PH19941A (ko)
PL (1) PL138793B1 (ko)
PT (1) PT78063A (ko)
RO (1) RO87706A (ko)
SU (1) SU1303028A3 (ko)
UA (1) UA6020A1 (ko)
ZA (1) ZA84869B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80961A0 (en) * 1985-12-18 1987-03-31 Lilly Co Eli Synthesis of nizatidine
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
DE3486032T2 (de) 1993-05-19
PL246097A1 (en) 1985-06-04
RO87706B (ro) 1985-10-01
FI840474A0 (fi) 1984-02-06
DK164906C (da) 1993-01-25
PT78063A (en) 1984-03-01
SU1303028A3 (ru) 1987-04-07
JPS59152378A (ja) 1984-08-31
HU194198B (en) 1988-01-28
GR81755B (ko) 1984-12-12
EG17702A (en) 1991-03-30
ES8601941A1 (es) 1985-11-01
JPH0576473B2 (ko) 1993-10-22
GB8403109D0 (en) 1984-03-07
DD216459A5 (de) 1984-12-12
EP0116452B1 (en) 1993-01-13
DK21292D0 (da) 1992-02-19
RO87706A (ro) 1985-10-31
AU559639B2 (en) 1987-03-19
AU2421584A (en) 1984-08-16
PL138793B1 (en) 1986-11-29
DK164501B (da) 1992-07-06
GB2134521B (en) 1986-10-01
UA6020A1 (uk) 1994-12-29
EP0116452A2 (en) 1984-08-22
ZA84869B (en) 1985-09-25
EP0116452A3 (en) 1987-04-29
NZ207046A (en) 1986-06-11
CS81284A2 (en) 1985-06-13
HU190527B (en) 1986-09-29
DK164906B (da) 1992-09-07
IE840274L (en) 1984-08-07
FI840474A (fi) 1984-08-08
IL70880A0 (en) 1984-05-31
CS240994B2 (en) 1986-03-13
PH19941A (en) 1986-08-14
ES529492A0 (es) 1985-11-01
ATE84530T1 (de) 1993-01-15
CA1221369A (en) 1987-05-05
IE56763B1 (en) 1991-12-04
DK21292A (da) 1992-02-19
KR860000767B1 (ko) 1986-06-23
KR840007591A (ko) 1984-12-08
DK51984A (da) 1984-08-08
DE3486032D1 (de) 1993-02-25
GB2134521A (en) 1984-08-15
DK51984D0 (da) 1984-02-06
IL70880A (en) 1987-01-30
BG45216A3 (ko) 1989-04-14

Similar Documents

Publication Publication Date Title
IT1123753B (it) 5-(4-piridil)-6-(4-fluorofenil)-2,3-diidromidazo (2,1-b) tiazolo e procedimento per la sua preparazione
DK164501C (da) Fremgangsmaade til fremstilling af nizatidin og mellemprodukt til brug ved fremgangsmaaden
IL68630A (en) Preparation of 2-guanidino-4-(2-(substituted amino)-4-imidazolyl)-thiazoles and novel intermediates used therefor
NO169284C (no) Fremgangsmaate for omdannelse av en polymorf krystallinsk form av buspiron-hydroklorid til dens andre polymorfe krystallinske form
DK522881A (da) Fremgangsmaade til omdannelse af et pentosanholdigt cellulosemateriale til xylose og glukose ved syrehydrolyse
SE8104541L (sv) Sett att framstella 5-substituerade dialursyror
DK164050C (da) 4-benzyloxy-3-pyrrolin-2-on samt anvendelse deraf til fremstilling af tetramsyre
DK36689D0 (da) Fremgangsmaade til fremstilling af et 16-methoxy-16-methyl-prostaglandin e1-derivat, samt ved fremgangsmaaden anvendelige mellemprodukter
FI910956A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2-(1-(pentyyli-3-guanidino)-2-metyyli-4-imidatsolyyli)tiatsolihemifosfaattihemihydraattisuolan valmistamiseksi
ES8800673A1 (es) Procedimiento de obtencion de un compuesto de guanidiltiazol, util como inhibidor de secrecion gastrica

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK